Abstract: The present invention relates to a stable sterilized parenteral formulation comprising an acid susceptible proton pump inhibitor. The formulation, a solid formulation comprising the acid susceptible proton pump inhibitor and optionally pharmaceutically acceptable excipients, has been sterilized in its final container by ionizing radiation. The container may consist of several compartments and separately contains a suitable solvent, which is sterilized, i.e. radiated, at the same time as the solid formulation. Alternatively, the suitable solvent is sterilized separately or aseptically manufactured. The solid formulation is dissolved in a suitable solvent before being administered to the patient, i.e. being prepared ex tempore. The present invention also relates to the prepared sterilized parenteral formulation, the stable solid formulation, processes for obtaining said parenteral formulation and the solid formulation as well as to the therapeutic uses thereof.

Abstract: A cellular communication system supporting packet data communication includes a number of switching arrangements for switching speech and/or circuit switched data. It also includes a number of packet data nodes, each controlling/serving the packet data communication in a number of packet paging areas. In each cell, a number of packet data communication channel resources are used for packet data communication, and each packet data node includes mobile station information handling devices keeping information about mobile stations registered in the cells covered by the packet data node. Cell information handling devices are further provided keeping information about packet data communication channel resources in the cells covered by the packet data node. Devices are provided for calculating which packet data communication channels are to be used for mobile stations after updating of a cell. Furthermore, devices are provided for keeping information about which cells have been updated and when a cell is updated.